Trials / Conditions / Growth Hormone Deficiency (GHD)

Growth Hormone Deficiency (GHD)

10 registered clinical trials studyying Growth Hormone Deficiency (GHD) — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency NCT07129759	Lumos Pharma	Phase 3
Recruiting	Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency NCT06948214	Lumos Pharma	Phase 3
Recruiting	REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density NCT07412782	Meyer Children's Hospital IRCCS	N/A
Not Yet Recruiting	Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency NCT07126288	Shenzhen Kexing Pharmaceutical Co., Ltd.	Phase 2 / Phase 3
Completed	Development of a Personalized Growth Hormone Treatment Profile (PGTP) Report for Pediatric Endocrinology NCT06830525	Luis Fernandez Luque	—
Completed	Hypothalamic-Stratified Nursing Pathway for Pediatric Craniopharyngioma NCT07342686	West China Hospital	—
Completed	Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children NCT02500316	OPKO Health, Inc.	Phase 2
Completed	Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children NCT01947907	Ascendis Pharma A/S	Phase 2
Terminated	Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study NCT01237340	EMD Serono	Phase 3
Unknown	Treatment of Children With Insufficient Secretion of Growth Hormone NCT00271518	LG Life Sciences	Phase 3